

US regulators have approved GlaxoSmithKline's treatment for chronic obstructive pulmonary disease, but the excitement was cooled by news that Denmark ...


(Refiled to improve headline, no change to text) * Green light generic copy of GSK's $8-billion drug Advair * Danish approval is first for product in ...


The FTSE small cap index closes 0.6 percent higher, beating gains of 0.1 percent on both the blue-chip FTSE 100 index and the FTSE 250 mid-cap index. ...


LONDON, Dec 18 (Reuters) - Vectura said its partner Sandoz had received Danish approval for an inhaled lung drug that analysts widely believe to be a ...


African Barrick Gold: Liberum Capital upgrades to hold with a target price of 147p. Amec: UBS reduces target price from 1200p to 1145p downgrading fr...